Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy.
Location: United States, California, Fremont
Employees: 11-50
Total raised: $15.4M
Founded date: 2006
Investors 4
| Date | Name | Website |
| - | Aisling Ca... | aislingcap... |
| - | Hercules C... | htgc.com |
| - | Vivo Capit... | vivocapita... |
| - | Trinity Ca... | trinitycap... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.02.2022 | - | $15.4M | - |
Mentions in press and media 9
| Date | Title | Description | Source |
| 09.02.2022 | Zosano Pharma Announces Pricing of $15.4 Million Public Offe... | FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinic... | marketscre... |
| 08.02.2022 | Zosano Pharma Announces Pricing of $15.4 Million Public Offe... | FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinic... | globenewsw... |
| 08.02.2022 | Zosano Pharma Announces Pricing of $15.4 Million Public Offe... | FREMONT, CA- February 08, 2022 — Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharma... | aislingcap... |
| 19.02.2018 | Life sciences startup Avro aims to deliver drugs to children... | Avro, a life sciences startup in Y Combinator’s current batch, is banking on a method to deliver med... | techcrunch... |
| 07.07.2015 | Morning Read: BioCardia files IPO with hopes of $50M, HHS se... | In response to the influx of Central American children immigrating to the U.S. over the last year, t... | medcitynew... |
| 18.01.2008 | VC funding up, biotech outpaces other industries | Venture-capital funding continued to rise in the fourth quarter, continuing a recent boom despite ec... | venturebea... |
| 15.11.2007 | Zosano Pharma raises $45M for needle-free drugs | See our story about this Fremont, Calif., specialty pharma in today’s daily briefing at VentureBeat ... | venturebea... |
| 15.11.2007 | Life sciences briefing: Thursday, Nov. 15, 2007 | Featured companies: BioVex, FullTurn Media, Humanetics, N Spine, Novitas Capital, Reliant Technologi... | venturebea... |
| - | Morning Read: BioCardia files IPO with hopes of $50M, HHS se... | TOP STORIES BioCardia, which is expecting to enter its lead cell-based therapy for cardiovascular d... | medcitynew... |